Clinical Trial Update: RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes [NA]

View source ↗

Summary

The RISCAID trial evaluating remote ischemic conditioning for diabetic angiopathy in peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Peripheral Arterial Disease | NA | Status: COMPLETED